Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,343 | 521 | 95.0% |
| Consulting Fee | $400.00 | 1 | 4.1% |
| Education | $89.97 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,756 | 121 | $0 (2024) |
| Novo Nordisk Inc | $1,417 | 91 | $0 (2024) |
| Dexcom, Inc. | $1,133 | 68 | $0 (2024) |
| Abbott Laboratories | $1,120 | 50 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $924.86 | 47 | $0 (2023) |
| Tandem Diabetes Care, Inc. | $550.41 | 5 | $0 (2024) |
| Amgen Inc. | $528.00 | 17 | $0 (2020) |
| Radius Health, Inc. | $267.46 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $263.74 | 16 | $0 (2019) |
| Medtronic MiniMed, Inc. | $256.07 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,250 | 66 | Abbott Laboratories ($473.26) |
| 2023 | $812.63 | 49 | Dexcom, Inc. ($410.43) |
| 2022 | $773.58 | 47 | Dexcom, Inc. ($373.63) |
| 2021 | $460.57 | 21 | Insulet Corporation ($115.56) |
| 2020 | $750.81 | 19 | Tandem Diabetes Care, Inc. ($400.00) |
| 2019 | $1,750 | 89 | Lilly USA, LLC ($401.96) |
| 2018 | $1,957 | 110 | Lilly USA, LLC ($492.45) |
| 2017 | $2,079 | 127 | Lilly USA, LLC ($379.07) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Diabetes Care | ||||||
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Diabetes Care | ||||||
| 12/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Endocrinology | ||||||
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: Diabetes Care | ||||||
| 09/06/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $83.58 | General |
| Category: Endocrinology | ||||||
| 09/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Diabetes | ||||||
| 09/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 598 | 3,860 | $209,703 | $117,749 |
| 2022 | 7 | 582 | 3,414 | $205,811 | $112,433 |
| 2021 | 9 | 558 | 3,067 | $176,248 | $99,054 |
| 2020 | 8 | 544 | 2,876 | $134,252 | $80,534 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 547 | $98,460 | $54,297 | 55.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 31 | 2,880 | $86,400 | $52,898 | 61.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $12,960 | $6,125 | 47.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 49 | 109 | $6,867 | $3,105 | 45.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 131 | 228 | $3,192 | $726.18 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 48 | $1,824 | $598.56 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 602 | $108,360 | $59,767 | 55.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 24 | 2,340 | $70,200 | $40,115 | 57.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $12,210 | $6,218 | 50.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 40 | 99 | $6,237 | $2,808 | 45.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $3,500 | $2,153 | 61.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 141 | 273 | $3,822 | $873.24 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 39 | $1,482 | $498.68 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 253 | 521 | $92,484 | $52,765 | 57.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 21 | 2,040 | $52,620 | $33,260 | 63.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 43 | 45 | $10,206 | $4,985 | 48.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 30 | 92 | $5,796 | $2,736 | 47.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,320 | $2,482 | 57.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 143 | 285 | $3,990 | $925.91 | 23.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,662 | $716.60 | 26.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 16 | $2,688 | $693.43 | 25.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 23 | 39 | $1,482 | $489.84 | 33.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 19 | 1,980 | $37,620 | $29,722 | 79.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 196 | 365 | $52,560 | $28,246 | 53.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 90 | 121 | $23,232 | $14,130 | 60.8% |
About Dr. Cynthia Ro, M.D
Dr. Cynthia Ro, M.D is a Internal Medicine healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598946790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cynthia Ro, M.D has received a total of $9,833 in payments from pharmaceutical and medical device companies, with $1,250 received in 2024. These payments were reported across 528 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($9,343).
As a Medicare-enrolled provider, Ro has provided services to 2,282 Medicare beneficiaries, totaling 13,217 services with total Medicare billing of $409,770. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Roseville, CA
- Active Since 11/16/2007
- Last Updated 11/12/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598946790
Products in Payments
- Dexcom G6 Transmitter (Medical Supply) $1,031
- HUMULIN (Drug) $535.26
- FREESTYLE LIBRE 3 (Device) $514.92
- TOUJEO (Drug) $512.14
- Ozempic (Drug) $474.87
- t:slim X2 insulin pump (Device) $400.00
- Victoza (Drug) $332.76
- FreeStyle Libre Pro (Device) $318.88
- TRADJENTA (Drug) $315.07
- Rybelsus (Drug) $289.23
- Minimed 670G System (Device) $278.71
- HUMALOG (Drug) $267.19
- Tymlos (Biological) $248.14
- EVENITY (Biological) $219.03
- Omnipod (Device) $218.27
- TRULICITY (Drug) $216.43
- JANUVIA (Drug) $214.40
- BAQSIMI (Drug) $177.63
- Prolia (Biological) $173.35
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $170.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseville
Dr. Antonious Attallah, M.d, M.D
Internal Medicine — Payments: $93,114
Thomas Hopkins, Md, MD
Internal Medicine — Payments: $58,379
Shyam Moudgil, Md, MD
Internal Medicine — Payments: $13,535
Dr. Jakkidi Reddy, Md, MD
Internal Medicine — Payments: $13,493
Alexandramary Kelada, Do, Mph, DO, MPH
Internal Medicine — Payments: $12,151
Shawn Aghili, M.d, M.D
Internal Medicine — Payments: $10,130